Author:
Pinchera B.,Scotto R.,Buonomo A.R.,Zappulo E.,Stagnaro F.,Gallicchio A.,Viceconte G.,Sardanelli A.,Mercinelli S.,Villari R.,Foggia M.,Gentile I.
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference76 articles.
1. A new application of mTOR inhibitor drugs as potential therapeutic agents for COVID-19;Mashayekhi-Sardoo;J Basic Clin Physiol Pharmacol,2021
2. Adapting the stress response: viral subversion of the mTOR signaling pathway;Le Sage;Viruses,2016
3. mTOR inhibition in COVID-19: A commentary and review of efficacy in RNA viruses;Karam;J Med Virol,2021
4. An open question: is it rational to inhibit the mTor-dependent pathway as COVID-19 therapy?;Terrazzano;Front Pharmacol,2020
5. The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment;Maiese;Curr Neurovasc Res,2020
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献